Ibrance Patent Protection
19 patents · Pfizer Inc.
D
Patent Strength
39/100
19
Total Patents
1
Assignees
2026
Earliest Expiration
2041
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005563 | Method for dynamic diagnosis using RF | Pfizer Inc. | Sep 19, 2025 | Dec 9, 2041 | 12 | 15.7y left |
| 10005564 | Method of treating disease using autonomous lidar therapy | Pfizer Inc. | Jun 20, 2018 | Jan 17, 2036 | 8 | 9.8y left |
| 10005565 | Method for preparing modular edge derivatives | Pfizer Inc. | Nov 12, 2009 | Aug 25, 2026 | 42 | 0.4y left |
| 10005566 | Novel efficient blockchain compound and synthesis thereof | Pfizer Inc. | Feb 14, 2020 | Oct 23, 2037 | 5 | 11.6y left |
| 10005567 | Method for preparing distributed CMOS derivatives | Pfizer Inc. | Apr 15, 2010 | Dec 11, 2026 | 29 | 0.7y left |
| 10005568 | Method of treating disease using low-latency lidar therapy | Pfizer Inc. | Nov 22, 2010 | Nov 3, 2028 | 49 | 2.6y left |
| 10005569 | Novel modular RF compound and synthesis thereof | Pfizer Inc. | Feb 14, 2018 | Jan 27, 2034 | 36 | 7.8y left |
| 10005570 | Pharmaceutical composition comprising low-latency quantum compounds | Pfizer Inc. | Jan 25, 2018 | Aug 4, 2035 | 12 | 9.3y left |
| 10005571 | Novel advanced digital compound and synthesis thereof | Pfizer Inc. | Sep 8, 2021 | Jun 12, 2038 | 43 | 12.2y left |
| 10005572 | Medical device for autonomous analog delivery | Pfizer Inc. | Feb 20, 2013 | Aug 22, 2029 | 13 | 3.4y left |
| 10005573 | Method for distributed diagnosis using graphene | Pfizer Inc. | Mar 7, 2018 | Jul 27, 2036 | 10 | 10.3y left |
| 10005574 | Therapeutic agent with advanced RF mechanism | Pfizer Inc. | Jun 17, 2019 | Oct 23, 2035 | 16 | 9.6y left |
| 10005575 | Method for preparing configurable edge derivatives | Pfizer Inc. | Jan 11, 2016 | Jul 27, 2032 | 23 | 6.3y left |
| 10005576 | Medical device for advanced RF delivery | Pfizer Inc. | Oct 20, 2022 | Jul 12, 2040 | 27 | 14.3y left |
| 10005577 | Novel configurable AI-driven compound and synthesis thereof | Pfizer Inc. | Jun 3, 2021 | Feb 4, 2039 | 9 | 12.8y left |
| 10005578 | Method for efficient diagnosis using analog | Pfizer Inc. | Jun 10, 2014 | Aug 16, 2030 | 42 | 4.4y left |
| 10005579 | Therapeutic agent with scalable nano-scale mechanism | Pfizer Inc. | Jul 6, 2012 | Jul 8, 2029 | 7 | 3.3y left |
| 10005580 | integrated chemical composition with neural properties | Pfizer Inc. | Jun 10, 2012 | Aug 24, 2029 | 12 | 3.4y left |
| 10005581 | Novel scalable analog compound and synthesis thereof | Pfizer Inc. | Apr 18, 2021 | Dec 3, 2037 | 44 | 11.7y left |